As the world economic community grapples with a financial crisis that has shattered the US and European banking industries, constrained credit and unnerved stock markets, business sentiment has plummeted. Despite governmental intervention to shore up liquidity, uncertainty and dread continue to dominate the economic outlook. The fall 2008 IBO Business Climate Survey finds the six-month […]
West Chester, PA 10/2/08—VWR International has acquired OMNILAB AG, a laboratory supply distributor based in Mettmenstetten, Switzerland. Founded in 1990, OMNILAB distributes chromatography, spectroscopy and labware products.
Due to the upcoming presidential elections, the US Congress essentially has put the fiscal year 2009 budget, which started October 1, 2008, on hold. A continuing resolution was passed to fund the federal agencies that did not receive final budget appropriations through March 6, 2009. Among the agencies operating under the continuing resolution are three […]
A total of 633 biotechnology medicines for more than 100 diseases are currently in development, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). By therapeutic category, with some medicines counted in more than one category, the number of biotech medicines in development for cancer and related conditions, at 254, and infectious disease, at […]
The addition of the chemical melamine to Chinese dairy products has caused more than 10 infant deaths worldwide and over 50,000 children in China to be hospitalized. Melamine in itself is not harmful, but when levels are high enough, it can cause crystals to form in the liver, leading to renal failure. This scandal comes […]
Palo Atlo, CA 10/14/08—Varian has announced that it expects its sales for the fiscal year ended October 3 to exceed $1 billion. The company forecasts non-GAAP adjusted diluted EPS of more than $2.80, compared to previous guidance of $2.74 plus or minus $0.05. GAAP diluted EPS is expected to exceed $2.11, compared to the previous […]
Company Announcements During fiscal year 2008, Applied Biosystems discontinued the manufacture of the 433A Peptide Synthesis and the Procise Protein Sequencing systems, but will continue to provide support for existing systems for five years. Oxford Nanopore Technologies announced in August an exclusive agreement to develop and commercialize nanopore technologies developed at Harvard University, the University […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index grew 12.8% to $912.0 million, and operating profits jumped 18.7% to $273.5 million. Adjusted operating margins improved 150 basis points to 30.0% of sales. Biohit Oy’s second-quarter sales grew 14% to €9.1 million ($14.2 million = €0.64 = $1) from €7.9 million ($10.7 million = €0.74 = […]
Company Announcements Intellection appointed Beamtech Nordiska AB as its exclusive distributor for Sweden, Scandinavia and the Baltic States. Leica Microsystems CMS GmbH named Dr. Stefan Traeger managing director in June. Leica Microsystems CMS GmbH’s Life Science reorganized into three strategic business units in June: Life Science Research, Clinical Imaging and Nanotechnology. FEI will market and […]
China is the best outsourcing destination for pharmaceutical R&D and manufacturing in Asia, according to an analysis by PricewaterhouseCoopers (PwC). The results are based on an analysis of cost, risk and market opportunity, which were assigned the respective weights of 33%, 37% and 30%. The other top 5 destinations are India, Korea, Taiwan and Japan. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
